相关实验视频
Updated: May 10, 2026
07:34
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
19.4K
面向个性化医疗:对败血症免疫治疗的范围审查
Marleen A Slim1,2, Niels van Mourik3,4, Lieke Bakkerus5
1Department of Intensive Care Medicine, Amsterdam University Medical Center, Meibergdreef 9, Room G3-220, 1105 AZ, Amsterdam, The Netherlands. m.a.slim@amsterdamumc.nl.
Critical care (London, England)
|May 28, 2024
概括
个性化免疫疗法,根据患者的免疫特征量身定制治疗,在败血症管理方面表现有前途. 这种方法将患者分为子组,可以克服以前的败血症免疫疗法的相互矛盾结果.
科学领域:
- * 关键护理医学 关键护理医学
- * 免疫学 免疫学
- * 翻译医学是一种翻译医学.
背景情况:
- *败血症仍然是一个危及生命的疾病,针对免疫失调的有效疗法有限.
- *目前对败血症病理生理学的理解需要新的治疗策略.
研究的目的:
- * 对成人败血症患者的免疫疗法进行文献审查.
- *强调个性化免疫疗法方法,通过患者的免疫特征和亚现象类型来定义,以指导治疗.
- * 确定个性化免疫疗法在败血症中的趋势和潜在益处.
主要方法:
- *对成年人败血症免疫调节疗法的随机对照试验和队列研究进行了范围审查.
- * 搜索的主要数据库 (PubMed,Embase,Cochrane CENTRAL,ClinicalTrials.gov) 截至 2024 年 1 月 29 日.
- *包括771项研究,分析了各种治疗目标和个性化方法的应用 (70项研究).
主要成果:
- * 9%的纳入研究采用个性化方法,使用基于温度,实验室,生物标志物或遗传变量的患者分层.
- * 败血症免疫疗法试验中的相互矛盾结果可能源于缺乏患者分层.
- *个性化免疫疗法方法显示了各种干预措施中临床益处的新兴趋势.
结论:
- *个性化免疫疗法,通过将败血症患者分成分组或子类型的分层,为改善治疗疗效提供了显著的希望.
- *未来的临床试验应侧重于个性化免疫疗法策略,以解决败血症引起的免疫失调.
- *这种方法可以克服以前非分层免疫疗法的局限性,从而导致更有效的败血症治疗方法.
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.